Enzorurong personal page - To The Moon

Enzorurong

Enzorurong

Pronouns: hee/hee

10Follow

4Followers

0Topic

0Badge

2021-06-12

Like and comment pls

15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir

2021-06-13

Like and comment pls

S&P ekes out gains to close languid week

2021-06-16

Like and reply pls

Here's a complete trader playbook for every outcome from the key Fed meeting

2021-06-15

Like and reply pls

Vaccine Stocks Slide After Novavax Shot Proves Highly Effective

2021-06-13

Comment and like pls

BRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11

2021-06-12

Like and comment pls

S&P ekes out gains to close languid week

2021-06-18

pls like and comment pls

Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma

2021-05-07

tough tough.. we all know there's a chip shortage and a shortage on touchscreens -> this will probably hit GM production too. So just monitor for now.

Here's Why We Think General Motors Is Well Worth Watching

2021-06-16

Like and reply pls

Michael "Big Short" Burry: This Is The Greatest Bubble Of All Time In All Things "By Two Orders Of Magnitude"

2021-06-12

Trend trader

Investor, Trader, Speculator: Which One Are You?

2021-06-10

$ON Semiconductor(ON)$ anyone crazy enough to be bearish on ON?

2021-05-07

monitor NXP, Infineon Technologies AG and Renesas Electronics Corp

U.S. lawmakers should prioritize automotive chips needs: industry

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582093977648076","uuid":"3582093977648076","gmtCreate":1619001111252,"gmtModify":1623488538872,"name":"Enzorurong","pinyin":"enzorurong","introduction":"","introductionEn":null,"signature":"Pronouns: hee/hee","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":10,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":166281354,"gmtCreate":1624011939778,"gmtModify":1703826512158,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"pls like and comment pls","listText":"pls like and comment pls","text":"pls like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166281354","repostId":"1166489816","repostType":4,"repost":{"id":"1166489816","kind":"news","pubTimestamp":1624009298,"share":"https://ttm.financial/m/news/1166489816?lang=&edition=fundamental","pubTime":"2021-06-18 17:41","market":"us","language":"en","title":"Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1166489816","media":"seekingalpha","summary":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine ","content":"<ul>\n <li>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase&nbsp;2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.</li>\n <li>The trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.</li>\n <li>Secondary endpoints include ORR in the single agent arms, duration of response, and safety.</li>\n <li>The first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.</li>\n <li>This Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.</li>\n <li>The Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).</li>\n <li>The BNT111-01 trial is being conducted in collaboration with Regeneron.</li>\n <li>BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed ...</p>\n\n<a href=\"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1166489816","content_text":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.\nThe trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.\nSecondary endpoints include ORR in the single agent arms, duration of response, and safety.\nThe first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.\nThis Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.\nThe Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).\nThe BNT111-01 trial is being conducted in collaboration with Regeneron.\nBioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant","news_type":1},"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160837353,"gmtCreate":1623778771372,"gmtModify":1703819286118,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Like and reply pls","listText":"Like and reply pls","text":"Like and reply pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/160837353","repostId":"1150591447","repostType":4,"repost":{"id":"1150591447","kind":"news","pubTimestamp":1623769391,"share":"https://ttm.financial/m/news/1150591447?lang=&edition=fundamental","pubTime":"2021-06-15 23:03","market":"us","language":"en","title":"Here's a complete trader playbook for every outcome from the key Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1150591447","media":"CNBC","summary":"The Federal Reserve’s all-important policy meeting this week is going to affect where investors put ","content":"<div>\n<p>The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's a complete trader playbook for every outcome from the key Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's a complete trader playbook for every outcome from the key Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"source_url":"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1150591447","content_text":"The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day meeting Wednesday, could start preliminary discussions about scaling back the unprecedented bond-buying programs that aided the economy during the pandemic. Some market participants believe it’s still too soon for the central bank to signal such a tapering action, while others think the Fed will be able to find a happy medium that won’t upset the markets.\nEach scenario has different investing implications as they are expected to make big moves across asset classes.\nHere’s a playbook for traders on every scenario from the central bank’s key meeting.\nIf the Fed signals it’s staying with easy policies\nThe Fed could reiterate its transitory stance on inflation, ignoring the pick-up in price pressures reflected in recent economic data. If the central bank says its not time to remove accommodative policies and it’s not concerned about inflation, investors should stick with hedges against rising prices like commodities and stocks with high pricing power, investment banks found.\nBank of America screened S&P 500 companies that its analysts believe have the most pricing power and ability to expand margins at times of rising prices. The stocks include a few chipmakers —Nvidia,Texas InstrumentsandBroadcom— as well as consumer plays likeHome Depot,NikeandPepsiCo.Energy dividend payerExxon Mobilis also on the list.\nUBS also developed a framework for scoring corporate pricing agility, which considers pricing power, margin momentum and input cost exposure. For pricing power, UBS quantified the extent to which a company can raise prices over and above costs. For margin momentum, UBS tracked corporate pricing trends using its proprietary pricing mapping.\nFor input cost exposure, UBS searched for companies with negative sentiment around commodity and transport costs on earnings calls.\n\nBillionaire hedge fund manager Paul Tudor Jones said earlier this week that investors should “go all in on the inflation trades” if the Fed keeps ignoring higher prices.\n“If they treat these numbers — which were material events, they were very material —if they treat them with nonchalance, I think it’s just a green light to bet heavily on every inflation trade,” Tudor Jones said on “Squawk Box”on Monday.\n“If they say, ‘We’re on path, things are good,’ then I would just go all in on the inflation trades. I’d probably buy commodities, buy crypto, buy gold,” added Tudor Jones, who called the stock market crash in 1987.\nThe legendary investor believe cryptocurrencies and other commodities are favorable inflation hedges. Other than buying the commodities outright, investors could also bet on related exchange-traded funds, like gold miner ETFs.\nThe VanEck Vectors Gold Miners ETF (GDX),the biggest gold miner ETF with more than $14 billion in assets under management, has outperformed the populargold ETF GLDso far this year.\nIf the Fed signals it’s time to start removing easy policies\nAnother widely speculated scenario is for the Fed to signal that it’s nearing the time to dial back easy policy saying it will start tapering soon and move up its forecast for a rate increase. Under such a case where the central bank isn’t sufficiently dovish, many expect bond yields to shoot higher.\n“It could easily move longer yields higher,” said Kristina Hooper, Invesco’s chief global market strategist. “A revised dot plot could be one way to do that if it shows the anticipation of earlier or more aggressive rate hikes. And Fed Chair Jay Powell could easily push rates up if he shares that the Fed has started discussing tapering or suggests tapering could start in the next several months.”\nTudor Jones warned that this scenario could lead to another taper tantrum that could cause a correction in stocks.\n“If they course correct, if they say, ‘We’ve got incoming data, we’ve accomplished our mission or we’re on the way very rapidly to accomplishing our mission on employment,’ then you’re going to get a taper tantrum,”Tudor Jones said on Monday. “You’re going to get a sell-off in fixed income. You’re going to get a correction in stocks.”\nCNBC Pro combed through the returns of all S&P 500 stocks during the last five significant spikes in the 10-year Treasury yield. These five periods of a sharp move in rates occurred between 2003 and 2006, 2008 and 2009, 2012 and 2013, 2016 and 2018, and 2020 through now.\nAfter we found the stocks that beat the market every time, we looked for the names that are well-loved by analysts on Wall Street today. The stocks’ average gains during those rising interest rate periods are listed below, along with the percentage of analysts with buy ratings right now.\n\nBank of America’s head of U.S. equity and quantitative strategy Savita Subramanian is advising clients to buy high-quality stocks when tapering nears. High-quality stocks have a “B+” or better S&P quality rating.\nSubramanian said during the 2013 taper tantrum, high-quality names outperformed their low-quality counterparts by 1.3 percentage points from peak to trough in May and June.\nA hint at removing stimulus could also hurt stocks that are most sensitive to the economic recovery, including cyclicals like financials, energy and materials.\n“More hawkish = lower growth. Cyclicals should underperform,” Dennis DeBusschere, macro research analyst at Evercore ISI, said in a note. “The fact that hawkish concerns are being brought up at the same time people believe the reflation trade is in trouble and you have a poor Cyclical backdrop.”\nSo far in 2021, the energy sector has been the biggest winner among the 11 S&P 500 groupings, up 46%. Financials and real estate both gained more than 20% this year.\nIf the Fed makes both camps happy\nA third scenario could occur in which the Fed signals that it is concerned about inflation, but the central bank is not yet ready to taper.\nIf Fed chair Jerome Powell admits the discussion of tapering but nothing has been decided, then the market will likely see a modest rally, led by tech stocks, according to Tom Essaye, founder of the Sevens Report.\n“This is essentially the outcome that Powell and the Fed have been telegraphing for the past several weeks,” Essaye said. “This would be a continuation of the past two weeks’ Goldilocks market outlook. This outcome would help the S&P 500 extend last week’s breakout.”\nInvestors have been rotating back to tech as of late with bond yields coming down. The tech-heavyNasdaq Compositehas rallied about 2.5% this month, hitting a record close on Monday, its first all-time high since April 26. In comparison, the S&P 500 has risen just under 1% in June.\n“This is what the Fed has been doing for the last several months — warning that an inflation surge was coming but that it is transitory so no need to taper,” Jim Paulsen, chief investment strategist at the Leuthold Group, told CNBC. “Moreover, this is probably the most expected outcome from the Fed meeting.”\n“Yes, there may be comments by members that the time to start talking about tapering is here, but I think Powell will continue to suggest that inflation is up as expected but is not yet acting any differently than anticipated,” added Paulsen.\nThis year’s pullback in tech stocks has opened some opportunities in high-quality names that are now trading at a discount, according to top-rated technology analyst Toni Sacconaghi of Bernstein.\nThe Wall Street firm found several technology stocks that have inexpensive valuations and are high in quality. Bernstein screened for the cheapest tech names based on their forward price-to-earnings ratio. The firm also assigned each stock with a quality score.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160835505,"gmtCreate":1623778697807,"gmtModify":1703819283841,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"&nbsp;Like and reply pls","listText":"&nbsp;Like and reply pls","text":"Like and reply pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/160835505","repostId":"1147269544","repostType":4,"repost":{"id":"1147269544","kind":"news","pubTimestamp":1623770166,"share":"https://ttm.financial/m/news/1147269544?lang=&edition=fundamental","pubTime":"2021-06-15 23:16","market":"us","language":"en","title":"Michael \"Big Short\" Burry: This Is The Greatest Bubble Of All Time In All Things \"By Two Orders Of Magnitude\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1147269544","media":"zerohedge","summary":"Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he p","content":"<p>Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he picked up on the theme of Weimar Germany and specifically its<b>hyperinflation, as the blueprint for what comes next</b>in a lengthy tweetstorm cribbing generously fromParsson's seminal work, warning that<b>:</b></p>\n<p><b>\"The US government is inviting inflation with its MMT-tinged policies. Brisk Debt/GDP, M2 increases while retail sales, PMI stage V recovery</b>. Trillions more stimulus &amp; re-opening to boost demand as employee and supply chain costs skyrocket.\"</p>\n<p>#ParadigmShift</p>\n<p>\"The life of the inflation in its ripening stage was a paradox which had its own unmistakable characteristics. One was the great wealth, at least of those favored by the boom..Many great fortunes sprang up overnight...The cities, had an aimless and wanton youth\"</p>\n<p>\"Prices in Germany were steady, and both business and the stock market were booming. The exchange rate of the mark against the dollar and other currencies actually rose for a time, and the mark was momentarily the strongest currency in the world\" on inflation's eve.</p>\n<p><b>\"Side by side with the wealth were the pockets of poverty. Greater numbers of people remained on the outside of the easy money, looking in but not able to enter. The crime rate soared.\"</b></p>\n<p><b>\"Accounts of the time tell of a progressive demoralization which crept over the common people, compounded of their weariness with the breakneck pace, to no visible purpose, and their fears from watching their own precarious positions slip while others grew so conspicuously rich.\"</b></p>\n<p>\"Almost any kind of business could make money. Business failures and bankruptcies became few. The boom suspended the normal processes of natural selection by which the nonessential and ineffective otherwise would have been culled out.\"</p>\n<p><b>\"Speculation alone, while adding nothing to Germany's wealth, became one of its largest activities. The fever to join in turning a quick mark infected nearly all classes..Everyone from the elevator operator up was playing the market.\"</b></p>\n<p>\"The volumes of turnover in securities on the Berlin Bourse became so high that the financial industry could not keep up with the paperwork...and the Bourse was obliged to close several days a week to work off the backlog\" #<i>robinhooddown</i></p>\n<p>\"all the marks that existed in the world in the summer of 1922 were not worth enough, by November of 1923, to buy a single&nbsp; newspaper or a tram ticket. That was the spectacular part of the collapse, but most of the real loss in money wealth had been suffered much earlier.\"</p>\n<p>\"Throughout these years the structure was quietly building itself up for the blow.<b>Germany's #inflationcycle ran not for a year but for nine years, representing eight years of gestation and only one year of #collapse.\"</b></p>\n<p>His punchline: the above was \"written in 1974 re: 1914-1923\" and then makes the ominous extrapolation that \"<b>2010-2021: Gestation</b>\" adding that \"when dollars might as well be falling from the sky...management teams get creative and ultimately take more risk.. paying out debt-financed dividends to investors or investing in risky growth opportunities has beaten a frugal mentality hands down.\"</p>\n<p><img src=\"https://static.tigerbbs.com/c531b21050b42425510a30125935555e\" tg-width=\"500\" tg-height=\"395\">And, as if reading from the same playbook,<b>Paul Tudor Jones warned yesterday that things are \"bat shit crazy\"</b>and if Jay Powell</p>\n<blockquote>\n <i><b>“The idea that inflation is transitory, to me ... that one just doesn’t work the way I see the world.\"</b></i>\n</blockquote>\n<p>All of which led to Burry's latest tweet warning this morning...</p>\n<blockquote>\n <i><b>\"People always ask me what is going on in the markets. It is simple. Greatest Speculative Bubble of All Time in All Things. By two orders of magnitude.</b></i>#FlyingPigs360\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/afafeb68134e031ca871659bd8dbc595\" tg-width=\"512\" tg-height=\"261\">In other words:<i><b>\"Brace!\"</b></i></p>\n<p>So what are you going to do about it?</p>\n<p>Tudor Jones had some simple advice: \"<b>buy commodities, buy crypto, buy gold.\"</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Michael \"Big Short\" Burry: This Is The Greatest Bubble Of All Time In All Things \"By Two Orders Of Magnitude\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMichael \"Big Short\" Burry: This Is The Greatest Bubble Of All Time In All Things \"By Two Orders Of Magnitude\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/michael-big-short-burry-greatest-bubble-all-time-all-things-two-orders-magnitude><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he picked up on the theme of Weimar Germany and specifically itshyperinflation, as the blueprint for ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/michael-big-short-burry-greatest-bubble-all-time-all-things-two-orders-magnitude\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.zerohedge.com/markets/michael-big-short-burry-greatest-bubble-all-time-all-things-two-orders-magnitude","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147269544","content_text":"Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he picked up on the theme of Weimar Germany and specifically itshyperinflation, as the blueprint for what comes nextin a lengthy tweetstorm cribbing generously fromParsson's seminal work, warning that:\n\"The US government is inviting inflation with its MMT-tinged policies. Brisk Debt/GDP, M2 increases while retail sales, PMI stage V recovery. Trillions more stimulus & re-opening to boost demand as employee and supply chain costs skyrocket.\"\n#ParadigmShift\n\"The life of the inflation in its ripening stage was a paradox which had its own unmistakable characteristics. One was the great wealth, at least of those favored by the boom..Many great fortunes sprang up overnight...The cities, had an aimless and wanton youth\"\n\"Prices in Germany were steady, and both business and the stock market were booming. The exchange rate of the mark against the dollar and other currencies actually rose for a time, and the mark was momentarily the strongest currency in the world\" on inflation's eve.\n\"Side by side with the wealth were the pockets of poverty. Greater numbers of people remained on the outside of the easy money, looking in but not able to enter. The crime rate soared.\"\n\"Accounts of the time tell of a progressive demoralization which crept over the common people, compounded of their weariness with the breakneck pace, to no visible purpose, and their fears from watching their own precarious positions slip while others grew so conspicuously rich.\"\n\"Almost any kind of business could make money. Business failures and bankruptcies became few. The boom suspended the normal processes of natural selection by which the nonessential and ineffective otherwise would have been culled out.\"\n\"Speculation alone, while adding nothing to Germany's wealth, became one of its largest activities. The fever to join in turning a quick mark infected nearly all classes..Everyone from the elevator operator up was playing the market.\"\n\"The volumes of turnover in securities on the Berlin Bourse became so high that the financial industry could not keep up with the paperwork...and the Bourse was obliged to close several days a week to work off the backlog\" #robinhooddown\n\"all the marks that existed in the world in the summer of 1922 were not worth enough, by November of 1923, to buy a single  newspaper or a tram ticket. That was the spectacular part of the collapse, but most of the real loss in money wealth had been suffered much earlier.\"\n\"Throughout these years the structure was quietly building itself up for the blow.Germany's #inflationcycle ran not for a year but for nine years, representing eight years of gestation and only one year of #collapse.\"\nHis punchline: the above was \"written in 1974 re: 1914-1923\" and then makes the ominous extrapolation that \"2010-2021: Gestation\" adding that \"when dollars might as well be falling from the sky...management teams get creative and ultimately take more risk.. paying out debt-financed dividends to investors or investing in risky growth opportunities has beaten a frugal mentality hands down.\"\nAnd, as if reading from the same playbook,Paul Tudor Jones warned yesterday that things are \"bat shit crazy\"and if Jay Powell\n\n“The idea that inflation is transitory, to me ... that one just doesn’t work the way I see the world.\"\n\nAll of which led to Burry's latest tweet warning this morning...\n\n\"People always ask me what is going on in the markets. It is simple. Greatest Speculative Bubble of All Time in All Things. By two orders of magnitude.#FlyingPigs360\"\n\nIn other words:\"Brace!\"\nSo what are you going to do about it?\nTudor Jones had some simple advice: \"buy commodities, buy crypto, buy gold.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":583,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184153854,"gmtCreate":1623691075578,"gmtModify":1704208889298,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Like and reply pls","listText":"Like and reply pls","text":"Like and reply pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/184153854","repostId":"2143738859","repostType":4,"repost":{"id":"2143738859","kind":"news","pubTimestamp":1623684317,"share":"https://ttm.financial/m/news/2143738859?lang=&edition=fundamental","pubTime":"2021-06-14 23:25","market":"us","language":"en","title":"Vaccine Stocks Slide After Novavax Shot Proves Highly Effective","url":"https://stock-news.laohu8.com/highlight/detail?id=2143738859","media":"Bloomberg","summary":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’","content":"<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.</p>\n<p>Stocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> dropped 6.1%. Even the consumer giant Johnson &amp; Johnson slipped 0.6%, slightly more than the S&amp;P 500 index as the broader market dropped back from Friday’s record highs.</p>\n<p>Novavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.</p>\n<p>But with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks Slide After Novavax Shot Proves Highly Effective</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks Slide After Novavax Shot Proves Highly Effective\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already ...</p>\n\n<a href=\"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143738859","content_text":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner BioNTech SE dropped 6.1%. Even the consumer giant Johnson & Johnson slipped 0.6%, slightly more than the S&P 500 index as the broader market dropped back from Friday’s record highs.\nNovavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.\nBut with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.","news_type":1},"isVote":1,"tweetType":1,"viewCount":718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182077883,"gmtCreate":1623549336342,"gmtModify":1704205803657,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Like and comment pls&nbsp;","listText":"Like and comment pls&nbsp;","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182077883","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","IVV":"标普500指数ETF","DOG":"道指反向ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","OEF":"标普100指数ETF-iShares","QQQ":"纳指100ETF","SDS":"两倍做空标普500ETF","DXD":"道指两倍做空ETF","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","OEX":"标普100",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF",".SPX":"S&P 500 Index","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182072946,"gmtCreate":1623549204185,"gmtModify":1704205798940,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Comment and like pls&nbsp;","listText":"Comment and like pls&nbsp;","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182072946","repostId":"2143783813","repostType":2,"repost":{"id":"2143783813","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623537805,"share":"https://ttm.financial/m/news/2143783813?lang=&edition=fundamental","pubTime":"2021-06-13 06:43","market":"us","language":"en","title":"BRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2143783813","media":"Reuters","summary":"June 12 (Reuters) -    * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12","content":"<html><body><p>June 12 (Reuters) - </p><p>   * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 373,413,945 DOSES DELIVERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS ADMINISTERED 308,112,728 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 306,509,795 DOSES ADMINISTERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS 173,391,711 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 172,758,350 INDIVIDUALS AS OF JUNE 11</p><p>   * U.S. CDC SAYS 143,119,077 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 12 VERSUS 142,095,530 INDIVIDUALS AS OF JUNE 11</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-13 06:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 12 (Reuters) - </p><p>   * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 373,413,945 DOSES DELIVERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS ADMINISTERED 308,112,728 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 306,509,795 DOSES ADMINISTERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS 173,391,711 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 172,758,350 INDIVIDUALS AS OF JUNE 11</p><p>   * U.S. CDC SAYS 143,119,077 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 12 VERSUS 142,095,530 INDIVIDUALS AS OF JUNE 11</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","JNJ":"强生"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143783813","content_text":"June 12 (Reuters) -    * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 373,413,945 DOSES DELIVERED AS OF JUNE 11   * U.S. CDC SAYS ADMINISTERED 308,112,728 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 306,509,795 DOSES ADMINISTERED AS OF JUNE 11   * U.S. CDC SAYS 173,391,711 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 172,758,350 INDIVIDUALS AS OF JUNE 11   * U.S. CDC SAYS 143,119,077 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 12 VERSUS 142,095,530 INDIVIDUALS AS OF JUNE 11 Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186124310,"gmtCreate":1623479724530,"gmtModify":1704204816543,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/186124310","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","IVV":"标普500指数ETF","DOG":"道指反向ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","OEF":"标普100指数ETF-iShares","QQQ":"纳指100ETF","SDS":"两倍做空标普500ETF","DXD":"道指两倍做空ETF","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","OEX":"标普100",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF",".SPX":"S&P 500 Index","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186125636,"gmtCreate":1623479629825,"gmtModify":1704204815088,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Trend trader&nbsp;","listText":"Trend trader&nbsp;","text":"Trend trader","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186125636","repostId":"1147474880","repostType":2,"isVote":1,"tweetType":1,"viewCount":514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186125344,"gmtCreate":1623479600288,"gmtModify":1704204815250,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/186125344","repostId":"2142206100","repostType":2,"repost":{"id":"2142206100","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623470400,"share":"https://ttm.financial/m/news/2142206100?lang=&edition=fundamental","pubTime":"2021-06-12 12:00","market":"us","language":"en","title":"15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir","url":"https://stock-news.laohu8.com/highlight/detail?id=2142206100","media":"Dow Jones","summary":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are m","content":"<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 12:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","PLTR":"Palantir Technologies Inc.","SNAP":"Snap Inc","CVNA":"Carvana Co.","PLUG":"普拉格能源"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142206100","content_text":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.\nBelow is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.\nMomentum ETF\nTo begin with a large group of momentum stocks, we can look at the iShares MSCI USA Momentum Factor ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&P 500 Growth Index.\nFor example, the largest holding of the ETF is Tesla Inc. $(TSLA)$, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to iShares (a subsidiary of BlackRock Inc. $(BLK)$). But shares of Merck & Co. Inc. $(MRK)$ are excluded from MTUM because even though iShares considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.\nSo keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the iShares MSCI USA Momentum Factor ETF:\n\n\n\nCompany\nTicker\nShare of MTUM\n\n\nTesla Inc.\nTSLA\n5.00%\n\n\nJPMorgan Chase & Co.\nJPM\n4.76%\n\n\nBerkshire Hathaway Inc. Class B\nBRK.B\n4.58%\n\n\nWalt Disney Co.\nDIS\n4.48%\n\n\n$Bank of America Corp(BAC-N)$.\nBAC\n4.29%\n\n\nPayPal Holdings Inc.\nPYPL\n3.66%\n\n\nWells Fargo & Co.\nWFC\n3.11%\n\n\nApplied Materials Inc.\nAMAT\n3.00%\n\n\nAlphabet Inc. Class C\nGOOG\n2.67%\n\n\nAlphabet Inc. Class A\nGOOGL\n2.45%\n\n\nGoldman Sachs Group Inc.\nGS\n2.30%\n\n\n(FactSet)\n\n\n\n\n\nActually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&P 500 , after the materials sector.\nMomentum stock screen -- expected sales growth\nThinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.\nBut revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.\nStarting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:\nThose are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the iShares S&P 500 Growth ETF $(IVW)$ (which tracks the entire S&P 500 Growth Index) trades for 4.2 times estimated 2023 sales.\nPlug Power Inc. $(PLUG)$ tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.\nSnap Inc. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.\nNovavax Inc. $(NVAX)$ expects to apply for FDA approval of its coronavirus vaccine during the third quarter.\nCarvana Co. (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.\nUber Technologies Inc. $(UBER)$ and Lyft Inc $(LYFT)$ are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .\nPalantir Technologies Inc. (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .\nEarnings\nSome of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:\nThose are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. $(AMZN)$ always trades at a high P/E. In comparison, the the iShares S&P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.\nWall Street's opinion\nHere's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:\nThe 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576201130234151","authorId":"3576201130234151","name":"JoshTay","avatar":"https://static.tigerbbs.com/6221f48f0e5f3a8cbcf13a9982af9401","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3576201130234151","idStr":"3576201130234151"},"content":"reply this reply pls","text":"reply this reply pls","html":"reply this reply pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189666684,"gmtCreate":1623256868248,"gmtModify":1704199606263,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ON\">$ON Semiconductor(ON)$</a> anyone crazy enough to be bearish on ON?","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ON\">$ON Semiconductor(ON)$</a> anyone crazy enough to be bearish on ON?","text":"$ON Semiconductor(ON)$ anyone crazy enough to be bearish on ON?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189666684","isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104414615,"gmtCreate":1620403000637,"gmtModify":1704343292683,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"monitor NXP, Infineon Technologies AG and Renesas Electronics Corp","listText":"monitor NXP, Infineon Technologies AG and Renesas Electronics Corp","text":"monitor NXP, Infineon Technologies AG and Renesas Electronics Corp","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/104414615","repostId":"1139108781","repostType":4,"repost":{"id":"1139108781","kind":"news","pubTimestamp":1620397966,"share":"https://ttm.financial/m/news/1139108781?lang=&edition=fundamental","pubTime":"2021-05-07 22:32","market":"us","language":"en","title":"U.S. lawmakers should prioritize automotive chips needs: industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1139108781","media":"Reuters","summary":"WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress","content":"<p>WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress to tie billions of dollars in government funding to boost semiconductor production to chip needs of automakers forced to slash production because of shortages.</p><p>Congress “should prioritize production of the semiconductors necessary to assemble vehicles here in the United States. This will ensure that motor vehicle manufacturers have a fair share of chips needed to meet consumer demand,” said the American Automotive Policy Council, Motor &amp; Equipment Manufacturers Association and UAW on Friday in a joint statement. Tens of thousands of auto workers have faced layoffs because of production cuts due to chip shortages.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. lawmakers should prioritize automotive chips needs: industry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. lawmakers should prioritize automotive chips needs: industry\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-07 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/autos-semiconductors-congress/u-s-lawmakers-should-prioritize-automotive-chips-needs-industry-idUSL1N2MU16V><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress to tie billions of dollars in government funding to boost semiconductor production to chip needs of...</p>\n\n<a href=\"https://www.reuters.com/article/autos-semiconductors-congress/u-s-lawmakers-should-prioritize-automotive-chips-needs-industry-idUSL1N2MU16V\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.reuters.com/article/autos-semiconductors-congress/u-s-lawmakers-should-prioritize-automotive-chips-needs-industry-idUSL1N2MU16V","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139108781","content_text":"WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress to tie billions of dollars in government funding to boost semiconductor production to chip needs of automakers forced to slash production because of shortages.Congress “should prioritize production of the semiconductors necessary to assemble vehicles here in the United States. This will ensure that motor vehicle manufacturers have a fair share of chips needed to meet consumer demand,” said the American Automotive Policy Council, Motor & Equipment Manufacturers Association and UAW on Friday in a joint statement. Tens of thousands of auto workers have faced layoffs because of production cuts due to chip shortages.","news_type":1},"isVote":1,"tweetType":1,"viewCount":489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104412423,"gmtCreate":1620402865162,"gmtModify":1704343290060,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582093977648076","idStr":"3582093977648076"},"themes":[],"htmlText":"tough tough.. we all know there's a chip shortage and a shortage on touchscreens -&gt; this will probably hit GM production too. So just monitor for now.","listText":"tough tough.. we all know there's a chip shortage and a shortage on touchscreens -&gt; this will probably hit GM production too. So just monitor for now.","text":"tough tough.. we all know there's a chip shortage and a shortage on touchscreens -> this will probably hit GM production too. So just monitor for now.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/104412423","repostId":"2133688169","repostType":4,"repost":{"id":"2133688169","kind":"news","pubTimestamp":1620399721,"share":"https://ttm.financial/m/news/2133688169?lang=&edition=fundamental","pubTime":"2021-05-07 23:02","market":"us","language":"en","title":"Here's Why We Think General Motors Is Well Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2133688169","media":"Simply Wall St.","summary":"It's only natural that many investors, especially those who are new to the game, prefer to buy share","content":"<p>It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled <i>Who Falls Prey to the Wolf of Wall Street?'</i> Leuz et. al. found that it is 'quite common' for investors to lose money by buying into 'pump and dump' schemes.</p><p>In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like <b>General Motors</b> (NYSE:GM). While profit is not necessarily a social good, it's easy to admire a business that can consistently produce it. Loss-making companies are always racing against time to reach financial sustainability, but time is often a friend of the profitable company, especially if it is growing.</p><p>View our latest analysis for General Motors</p><h3>General Motors's Earnings Per Share Are Growing.</h3><p>The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. That means EPS growth is considered a real positive by most successful long-term investors. As a tree reaches steadily for the sky, General Motors's EPS has grown 31% each year, compound, over three years. If the company can sustain that sort of growth, we'd expect shareholders to come away winners.</p><p>Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. I note that General Motors's revenue <i>from operations</i> was lower than its revenue in the last twelve months, so that could distort my analysis of its margins. General Motors's EBIT margins have actually improved by 3.7 percentage points in the last year, to reach 8.9%, but, on the flip side, revenue was down 9.5%. That's not ideal.</p><p>You can take a look at the company's revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers.</p><p><img src=\"https://static.tigerbbs.com/2f3531ee5b167e8ef9aa142801c39a05\" tg-width=\"821\" tg-height=\"560\" referrerpolicy=\"no-referrer\">NYSE:GM Earnings and Revenue History May 7th 2021</p><p>You don't drive with your eyes on the rear-view mirror, so you might be more interested in this <b>free</b> report showing analyst forecasts for General Motors's <b>future</b> profits.</p><h3>Are General Motors Insiders Aligned With All Shareholders?</h3><p>Like standing at the lookout, surveying the horizon at sunrise, insider buying, for some investors, sparks joy. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. However, insiders are sometimes wrong, and we don't know the exact thinking behind their acquisitions.</p><p>It's good to see General Motors insiders walking the walk, by spending US$536k on shares in just twelve months. When you contrast that with the complete lack of sales, it's easy for shareholders to brim with joyful expectancy. It is also worth noting that it was Independent Director Patricia Russo who made the biggest single purchase, worth US$294k, paying US$23.18 per share.</p><p>On top of the insider buying, it's good to see that General Motors insiders have a valuable investment in the business. Notably, they have an enormous stake in the company, worth US$126m. This suggests to me that leadership will be very mindful of shareholders' interests when making decisions!</p><h3>Is General Motors Worth Keeping An Eye On?</h3><p>You can't deny that General Motors has grown its earnings per share at a very impressive rate. That's attractive. On top of that, insiders own a significant stake in the company and have been buying more shares. So it's fair to say I think this stock may well deserve a spot on your watchlist. We don't want to rain on the parade too much, but we did also find <b>1 warning sign for General Motors</b> that you need to be mindful of.</p><p>There are plenty of other companies that have insiders buying up shares. So if you like the sound of General Motors, you'll probably love this <b>free</b> list of growing companies that insiders are buying.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why We Think General Motors Is Well Worth Watching</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why We Think General Motors Is Well Worth Watching\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-07 23:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/heres-why-think-general-motors-092301076.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-why-think-general-motors-092301076.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BGC":"BGC GROUP","GM":"通用汽车"},"source_url":"https://finance.yahoo.com/news/heres-why-think-general-motors-092301076.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2133688169","content_text":"It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled Who Falls Prey to the Wolf of Wall Street?' Leuz et. al. found that it is 'quite common' for investors to lose money by buying into 'pump and dump' schemes.In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like General Motors (NYSE:GM). While profit is not necessarily a social good, it's easy to admire a business that can consistently produce it. Loss-making companies are always racing against time to reach financial sustainability, but time is often a friend of the profitable company, especially if it is growing.View our latest analysis for General MotorsGeneral Motors's Earnings Per Share Are Growing.The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. That means EPS growth is considered a real positive by most successful long-term investors. As a tree reaches steadily for the sky, General Motors's EPS has grown 31% each year, compound, over three years. If the company can sustain that sort of growth, we'd expect shareholders to come away winners.Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. I note that General Motors's revenue from operations was lower than its revenue in the last twelve months, so that could distort my analysis of its margins. General Motors's EBIT margins have actually improved by 3.7 percentage points in the last year, to reach 8.9%, but, on the flip side, revenue was down 9.5%. That's not ideal.You can take a look at the company's revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers.NYSE:GM Earnings and Revenue History May 7th 2021You don't drive with your eyes on the rear-view mirror, so you might be more interested in this free report showing analyst forecasts for General Motors's future profits.Are General Motors Insiders Aligned With All Shareholders?Like standing at the lookout, surveying the horizon at sunrise, insider buying, for some investors, sparks joy. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. However, insiders are sometimes wrong, and we don't know the exact thinking behind their acquisitions.It's good to see General Motors insiders walking the walk, by spending US$536k on shares in just twelve months. When you contrast that with the complete lack of sales, it's easy for shareholders to brim with joyful expectancy. It is also worth noting that it was Independent Director Patricia Russo who made the biggest single purchase, worth US$294k, paying US$23.18 per share.On top of the insider buying, it's good to see that General Motors insiders have a valuable investment in the business. Notably, they have an enormous stake in the company, worth US$126m. This suggests to me that leadership will be very mindful of shareholders' interests when making decisions!Is General Motors Worth Keeping An Eye On?You can't deny that General Motors has grown its earnings per share at a very impressive rate. That's attractive. On top of that, insiders own a significant stake in the company and have been buying more shares. So it's fair to say I think this stock may well deserve a spot on your watchlist. We don't want to rain on the parade too much, but we did also find 1 warning sign for General Motors that you need to be mindful of.There are plenty of other companies that have insiders buying up shares. So if you like the sound of General Motors, you'll probably love this free list of growing companies that insiders are buying.","news_type":1},"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":186125344,"gmtCreate":1623479600288,"gmtModify":1704204815250,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/186125344","repostId":"2142206100","repostType":2,"repost":{"id":"2142206100","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623470400,"share":"https://ttm.financial/m/news/2142206100?lang=&edition=fundamental","pubTime":"2021-06-12 12:00","market":"us","language":"en","title":"15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir","url":"https://stock-news.laohu8.com/highlight/detail?id=2142206100","media":"Dow Jones","summary":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are m","content":"<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-12 12:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Several companies on a stock screen have estimated two-year revenue growth of over 100%.</p>\n<p>There are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.</p>\n<p>Below is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.</p>\n<p>Momentum ETF</p>\n<p>To begin with a large group of momentum stocks, we can look at the <a href=\"https://laohu8.com/S/MTUM\">iShares MSCI USA Momentum Factor</a> ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&amp;P 500 Growth Index.</p>\n<p>For example, the largest holding of the ETF is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to <a href=\"https://laohu8.com/S/EEME\">iShares</a> (a subsidiary of BlackRock Inc. <a href=\"https://laohu8.com/S/BLK\">$(BLK)$</a>). But shares of Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> are excluded from MTUM because even though <a href=\"https://laohu8.com/S/EGRW\">iShares</a> considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.</p>\n<p>So keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the <a href=\"https://laohu8.com/S/IHPXF\">iShares MSCI</a> USA Momentum Factor ETF:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Ticker</td>\n   <td>Share of MTUM</td>\n  </tr>\n  <tr>\n   <td>Tesla Inc.</td>\n   <td>TSLA</td>\n   <td>5.00%</td>\n  </tr>\n  <tr>\n   <td>JPMorgan Chase &amp; Co.</td>\n   <td>JPM</td>\n   <td>4.76%</td>\n  </tr>\n  <tr>\n   <td>Berkshire Hathaway Inc. Class B</td>\n   <td>BRK.B</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td>Walt Disney Co.</td>\n   <td>DIS</td>\n   <td>4.48%</td>\n  </tr>\n  <tr>\n   <td>$Bank of America Corp(BAC-N)$.</td>\n   <td>BAC</td>\n   <td>4.29%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.</td>\n   <td>PYPL</td>\n   <td>3.66%</td>\n  </tr>\n  <tr>\n   <td>Wells Fargo &amp; Co.</td>\n   <td>WFC</td>\n   <td>3.11%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>3.00%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C</td>\n   <td>GOOG</td>\n   <td>2.67%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class A</td>\n   <td>GOOGL</td>\n   <td>2.45%</td>\n  </tr>\n  <tr>\n   <td>Goldman Sachs Group Inc.</td>\n   <td>GS</td>\n   <td>2.30%</td>\n  </tr>\n  <tr>\n   <td>(FactSet)</td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Actually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&amp;P 500 , after the materials sector.</p>\n<p>Momentum stock screen -- expected sales growth</p>\n<p>Thinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.</p>\n<p>But revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.</p>\n<p>Starting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:</p>\n<p>Those are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the <a href=\"https://laohu8.com/S/EMDI\">iShares</a> S&amp;P 500 Growth ETF <a href=\"https://laohu8.com/S/IVW\">$(IVW)$</a> (which tracks the entire S&amp;P 500 Growth Index) trades for 4.2 times estimated 2023 sales.</p>\n<p>Plug Power Inc. <a href=\"https://laohu8.com/S/PLUG\">$(PLUG)$</a> tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.</p>\n<p><a href=\"https://laohu8.com/S/SNAP\">Snap Inc</a>. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.</p>\n<p>Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> expects to apply for FDA approval of its coronavirus vaccine during the third quarter.</p>\n<p><a href=\"https://laohu8.com/S/CVNA\">Carvana Co.</a> (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.</p>\n<p>Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a> and Lyft Inc <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .</p>\n<p><a href=\"https://laohu8.com/S/PLTR\">Palantir Technologies Inc.</a> (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .</p>\n<p>Earnings</p>\n<p>Some of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:</p>\n<p>Those are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> always trades at a high P/E. In comparison, the the <a href=\"https://laohu8.com/S/EMEY\">iShares</a> S&amp;P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.</p>\n<p>Wall Street's opinion</p>\n<p>Here's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:</p>\n<p>The 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","PLTR":"Palantir Technologies Inc.","SNAP":"Snap Inc","CVNA":"Carvana Co.","PLUG":"普拉格能源"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142206100","content_text":"Several companies on a stock screen have estimated two-year revenue growth of over 100%.\nThere are many broad approaches to the stock market for selecting individual companies or groups for investments. Momentum investing -- trying to ride the wave of other investors' sentiment -- is popular for day-traders, especially during the current meme-stock craze. But it can also work over the long term.\nBelow is a list of momentum stocks of companies expected to show the strongest sales growth over the next two years.\nMomentum ETF\nTo begin with a large group of momentum stocks, we can look at the iShares MSCI USA Momentum Factor ETF (MTUM). This is the largest U.S. ETF that follows a momentum strategy, according to Mark Hulbert performance relative to its benchmark, the S&P 500 Growth Index.\nFor example, the largest holding of the ETF is Tesla Inc. $(TSLA)$, which \"has experienced strong risk-adjusted performance related to the market over the past 12 months,\" according to iShares (a subsidiary of BlackRock Inc. $(BLK)$). But shares of Merck & Co. Inc. $(MRK)$ are excluded from MTUM because even though iShares considered its 12-month return \"attractive,\" the stock's six-month risk-adjusted return underperformed the benchmark.\nSo keeping in mind the weighting by price performance relative to the index, tempered by volatility (going back as much as three years), here are the top 10 holdings of the iShares MSCI USA Momentum Factor ETF:\n\n\n\nCompany\nTicker\nShare of MTUM\n\n\nTesla Inc.\nTSLA\n5.00%\n\n\nJPMorgan Chase & Co.\nJPM\n4.76%\n\n\nBerkshire Hathaway Inc. Class B\nBRK.B\n4.58%\n\n\nWalt Disney Co.\nDIS\n4.48%\n\n\n$Bank of America Corp(BAC-N)$.\nBAC\n4.29%\n\n\nPayPal Holdings Inc.\nPYPL\n3.66%\n\n\nWells Fargo & Co.\nWFC\n3.11%\n\n\nApplied Materials Inc.\nAMAT\n3.00%\n\n\nAlphabet Inc. Class C\nGOOG\n2.67%\n\n\nAlphabet Inc. Class A\nGOOGL\n2.45%\n\n\nGoldman Sachs Group Inc.\nGS\n2.30%\n\n\n(FactSet)\n\n\n\n\n\nActually, there are 11 stocks listed, as MTUM holds both share classes of Alphabet Inc. Banks and insurers make up half the list, which makes sense because financials have been the second-best performing sector in the S&P 500 , after the materials sector.\nMomentum stock screen -- expected sales growth\nThinking again about financials, they have had plenty of momentum as investors have gained confidence the U.S. economy will continue roaring back from the damage caused by the coronavirus pandemic.\nBut revenue growth can be an important driver, especially for individual stock prices over the long term. From here, the financials might not be the best place to look for rapidly rising revenue over the next two years.\nStarting with the 125 momentum stocks held by MTUM, here are the 15 companies expected by analysts polled by FactSet to increase revenue the most over the next two calendar years, with 2021 as the baseline. The figures are in millions of dollars:\nThose are stellar sales-growth numbers -- if the analysts are close to being correct. Many of the stocks are also expensive relative to the expected 2023 sales numbers. In comparison, the iShares S&P 500 Growth ETF $(IVW)$ (which tracks the entire S&P 500 Growth Index) trades for 4.2 times estimated 2023 sales.\nPlug Power Inc. $(PLUG)$ tops the list, with analysts expecting sales to increase to $1.1 billion in 2023. The company said on June 10 it would build a hydrogen-production plant in Camden County, Ga.\nSnap Inc. (SNAP) CEO Evan Spiegal said recently the company had grown to 500 million active daily users and that almost half of U.S. smartphone users were using Snapchat.\nNovavax Inc. $(NVAX)$ expects to apply for FDA approval of its coronavirus vaccine during the third quarter.\nCarvana Co. (CVNA) has been on a tear, with used-car demand spiking in the wake of component shortages for automobile production. The company's sales by units increased 76% in the first quarter from a year earlier.\nUber Technologies Inc. $(UBER)$ and Lyft Inc $(LYFT)$ are also expected to ride the economic recovery wave, although analysts expect Lyft to take longer to exceed its pre-pandemic revenue level .\nPalantir Technologies Inc. (PLTR) rounds out the list. The developer of software used by government defense and intelligence agencies was included in this analysis of meme stocks .\nEarnings\nSome of these companies are still in relatively early growth stages, and aren't expected to achieve full-year profitability until 2023. Here are consensus earnings-per-share estimates for three years:\nThose are very high price-to-earnings ratios based on current stock prices and consensus estimates for 2023. But for rapidly growing companies, earnings typically aren't a priority, which explains why Amazon.com Inc. $(AMZN)$ always trades at a high P/E. In comparison, the the iShares S&P 500 Growth ETF trades for 23.3 times its weighted aggregate consensus earnings estimate for 2023.\nWall Street's opinion\nHere's a summary of opinion about the 15 companies held by MTUM that analysts expect to grow their revenue the most over the next two years:\nThe 12-month price targets may not be useful -- for traders, this is an eternity; it may be a short period for long-term investors looking to profit for years as sales (and hopefully earnings, eventually) compound. It is important to do your own research and form your own opinion about a company's financial health and its ability to remain competitive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576201130234151","authorId":"3576201130234151","name":"JoshTay","avatar":"https://static.tigerbbs.com/6221f48f0e5f3a8cbcf13a9982af9401","crmLevel":5,"crmLevelSwitch":0,"idStr":"3576201130234151","authorIdStr":"3576201130234151"},"content":"reply this reply pls","text":"reply this reply pls","html":"reply this reply pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182077883,"gmtCreate":1623549336342,"gmtModify":1704205803657,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Like and comment pls&nbsp;","listText":"Like and comment pls&nbsp;","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182077883","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","IVV":"标普500指数ETF","DOG":"道指反向ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","OEF":"标普100指数ETF-iShares","QQQ":"纳指100ETF","SDS":"两倍做空标普500ETF","DXD":"道指两倍做空ETF","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","OEX":"标普100",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF",".SPX":"S&P 500 Index","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160837353,"gmtCreate":1623778771372,"gmtModify":1703819286118,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Like and reply pls","listText":"Like and reply pls","text":"Like and reply pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/160837353","repostId":"1150591447","repostType":4,"repost":{"id":"1150591447","kind":"news","pubTimestamp":1623769391,"share":"https://ttm.financial/m/news/1150591447?lang=&edition=fundamental","pubTime":"2021-06-15 23:03","market":"us","language":"en","title":"Here's a complete trader playbook for every outcome from the key Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1150591447","media":"CNBC","summary":"The Federal Reserve’s all-important policy meeting this week is going to affect where investors put ","content":"<div>\n<p>The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's a complete trader playbook for every outcome from the key Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's a complete trader playbook for every outcome from the key Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"source_url":"https://www.cnbc.com/2021/06/15/heres-a-complete-trader-playbook-for-every-outcome-from-the-key-fed-meeting.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1150591447","content_text":"The Federal Reserve’s all-important policy meeting this week is going to affect where investors put their money to work going forward.\nThe Federal Open Market Committee,which will conclude its two-day meeting Wednesday, could start preliminary discussions about scaling back the unprecedented bond-buying programs that aided the economy during the pandemic. Some market participants believe it’s still too soon for the central bank to signal such a tapering action, while others think the Fed will be able to find a happy medium that won’t upset the markets.\nEach scenario has different investing implications as they are expected to make big moves across asset classes.\nHere’s a playbook for traders on every scenario from the central bank’s key meeting.\nIf the Fed signals it’s staying with easy policies\nThe Fed could reiterate its transitory stance on inflation, ignoring the pick-up in price pressures reflected in recent economic data. If the central bank says its not time to remove accommodative policies and it’s not concerned about inflation, investors should stick with hedges against rising prices like commodities and stocks with high pricing power, investment banks found.\nBank of America screened S&P 500 companies that its analysts believe have the most pricing power and ability to expand margins at times of rising prices. The stocks include a few chipmakers —Nvidia,Texas InstrumentsandBroadcom— as well as consumer plays likeHome Depot,NikeandPepsiCo.Energy dividend payerExxon Mobilis also on the list.\nUBS also developed a framework for scoring corporate pricing agility, which considers pricing power, margin momentum and input cost exposure. For pricing power, UBS quantified the extent to which a company can raise prices over and above costs. For margin momentum, UBS tracked corporate pricing trends using its proprietary pricing mapping.\nFor input cost exposure, UBS searched for companies with negative sentiment around commodity and transport costs on earnings calls.\n\nBillionaire hedge fund manager Paul Tudor Jones said earlier this week that investors should “go all in on the inflation trades” if the Fed keeps ignoring higher prices.\n“If they treat these numbers — which were material events, they were very material —if they treat them with nonchalance, I think it’s just a green light to bet heavily on every inflation trade,” Tudor Jones said on “Squawk Box”on Monday.\n“If they say, ‘We’re on path, things are good,’ then I would just go all in on the inflation trades. I’d probably buy commodities, buy crypto, buy gold,” added Tudor Jones, who called the stock market crash in 1987.\nThe legendary investor believe cryptocurrencies and other commodities are favorable inflation hedges. Other than buying the commodities outright, investors could also bet on related exchange-traded funds, like gold miner ETFs.\nThe VanEck Vectors Gold Miners ETF (GDX),the biggest gold miner ETF with more than $14 billion in assets under management, has outperformed the populargold ETF GLDso far this year.\nIf the Fed signals it’s time to start removing easy policies\nAnother widely speculated scenario is for the Fed to signal that it’s nearing the time to dial back easy policy saying it will start tapering soon and move up its forecast for a rate increase. Under such a case where the central bank isn’t sufficiently dovish, many expect bond yields to shoot higher.\n“It could easily move longer yields higher,” said Kristina Hooper, Invesco’s chief global market strategist. “A revised dot plot could be one way to do that if it shows the anticipation of earlier or more aggressive rate hikes. And Fed Chair Jay Powell could easily push rates up if he shares that the Fed has started discussing tapering or suggests tapering could start in the next several months.”\nTudor Jones warned that this scenario could lead to another taper tantrum that could cause a correction in stocks.\n“If they course correct, if they say, ‘We’ve got incoming data, we’ve accomplished our mission or we’re on the way very rapidly to accomplishing our mission on employment,’ then you’re going to get a taper tantrum,”Tudor Jones said on Monday. “You’re going to get a sell-off in fixed income. You’re going to get a correction in stocks.”\nCNBC Pro combed through the returns of all S&P 500 stocks during the last five significant spikes in the 10-year Treasury yield. These five periods of a sharp move in rates occurred between 2003 and 2006, 2008 and 2009, 2012 and 2013, 2016 and 2018, and 2020 through now.\nAfter we found the stocks that beat the market every time, we looked for the names that are well-loved by analysts on Wall Street today. The stocks’ average gains during those rising interest rate periods are listed below, along with the percentage of analysts with buy ratings right now.\n\nBank of America’s head of U.S. equity and quantitative strategy Savita Subramanian is advising clients to buy high-quality stocks when tapering nears. High-quality stocks have a “B+” or better S&P quality rating.\nSubramanian said during the 2013 taper tantrum, high-quality names outperformed their low-quality counterparts by 1.3 percentage points from peak to trough in May and June.\nA hint at removing stimulus could also hurt stocks that are most sensitive to the economic recovery, including cyclicals like financials, energy and materials.\n“More hawkish = lower growth. Cyclicals should underperform,” Dennis DeBusschere, macro research analyst at Evercore ISI, said in a note. “The fact that hawkish concerns are being brought up at the same time people believe the reflation trade is in trouble and you have a poor Cyclical backdrop.”\nSo far in 2021, the energy sector has been the biggest winner among the 11 S&P 500 groupings, up 46%. Financials and real estate both gained more than 20% this year.\nIf the Fed makes both camps happy\nA third scenario could occur in which the Fed signals that it is concerned about inflation, but the central bank is not yet ready to taper.\nIf Fed chair Jerome Powell admits the discussion of tapering but nothing has been decided, then the market will likely see a modest rally, led by tech stocks, according to Tom Essaye, founder of the Sevens Report.\n“This is essentially the outcome that Powell and the Fed have been telegraphing for the past several weeks,” Essaye said. “This would be a continuation of the past two weeks’ Goldilocks market outlook. This outcome would help the S&P 500 extend last week’s breakout.”\nInvestors have been rotating back to tech as of late with bond yields coming down. The tech-heavyNasdaq Compositehas rallied about 2.5% this month, hitting a record close on Monday, its first all-time high since April 26. In comparison, the S&P 500 has risen just under 1% in June.\n“This is what the Fed has been doing for the last several months — warning that an inflation surge was coming but that it is transitory so no need to taper,” Jim Paulsen, chief investment strategist at the Leuthold Group, told CNBC. “Moreover, this is probably the most expected outcome from the Fed meeting.”\n“Yes, there may be comments by members that the time to start talking about tapering is here, but I think Powell will continue to suggest that inflation is up as expected but is not yet acting any differently than anticipated,” added Paulsen.\nThis year’s pullback in tech stocks has opened some opportunities in high-quality names that are now trading at a discount, according to top-rated technology analyst Toni Sacconaghi of Bernstein.\nThe Wall Street firm found several technology stocks that have inexpensive valuations and are high in quality. Bernstein screened for the cheapest tech names based on their forward price-to-earnings ratio. The firm also assigned each stock with a quality score.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184153854,"gmtCreate":1623691075578,"gmtModify":1704208889298,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Like and reply pls","listText":"Like and reply pls","text":"Like and reply pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/184153854","repostId":"2143738859","repostType":4,"repost":{"id":"2143738859","kind":"news","pubTimestamp":1623684317,"share":"https://ttm.financial/m/news/2143738859?lang=&edition=fundamental","pubTime":"2021-06-14 23:25","market":"us","language":"en","title":"Vaccine Stocks Slide After Novavax Shot Proves Highly Effective","url":"https://stock-news.laohu8.com/highlight/detail?id=2143738859","media":"Bloomberg","summary":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’","content":"<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.</p>\n<p>Stocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> dropped 6.1%. Even the consumer giant Johnson &amp; Johnson slipped 0.6%, slightly more than the S&amp;P 500 index as the broader market dropped back from Friday’s record highs.</p>\n<p>Novavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.</p>\n<p>But with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks Slide After Novavax Shot Proves Highly Effective</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks Slide After Novavax Shot Proves Highly Effective\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already ...</p>\n\n<a href=\"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞","BNTX":"BioNTech SE"},"source_url":"https://finance.yahoo.com/news/vaccine-stocks-slide-novavax-shot-145617752.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143738859","content_text":"(Bloomberg) -- The world’s top makers of Covid-19 vaccines are dropping after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.\nStocks tied to inoculations already cleared for emergency use fell in Monday’s trading, led by Moderna Inc.’s slide of as much as 9.5%. Pfizer Inc. fell 1.6% and the drugmaker’s German partner BioNTech SE dropped 6.1%. Even the consumer giant Johnson & Johnson slipped 0.6%, slightly more than the S&P 500 index as the broader market dropped back from Friday’s record highs.\nNovavax itself wasn’t immune from the downdraft it created, with the stock reversing a 9.5% gain on Monday to fall about 1%. The shot’s efficacy was better than Wall Street was expecting amid the spread of more resistant variants, and that’s raising the specter of new competition. Novavax now has “a viable alternative to mRNA vaccines,” like Pfizer and BioNTech or Moderna’s shots, an analyst at Jefferies said.\nBut with Novavax up 91% so far this year and after a more than 2,700% leap in 2020, it wasn’t enough to further bolster shares. Biotech stocks often climb ahead of highly watched catalyst, only to give back gains even after a positive update.","news_type":1},"isVote":1,"tweetType":1,"viewCount":718,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182072946,"gmtCreate":1623549204185,"gmtModify":1704205798940,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Comment and like pls&nbsp;","listText":"Comment and like pls&nbsp;","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/182072946","repostId":"2143783813","repostType":2,"repost":{"id":"2143783813","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623537805,"share":"https://ttm.financial/m/news/2143783813?lang=&edition=fundamental","pubTime":"2021-06-13 06:43","market":"us","language":"en","title":"BRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2143783813","media":"Reuters","summary":"June 12 (Reuters) -    * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12","content":"<html><body><p>June 12 (Reuters) - </p><p>   * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 373,413,945 DOSES DELIVERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS ADMINISTERED 308,112,728 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 306,509,795 DOSES ADMINISTERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS 173,391,711 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 172,758,350 INDIVIDUALS AS OF JUNE 11</p><p>   * U.S. CDC SAYS 143,119,077 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 12 VERSUS 142,095,530 INDIVIDUALS AS OF JUNE 11</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-U.S. CDC Says Delivered 374,397,205 Doses Of COVID-19 Vaccine As Of June 12 Versus 373,413,945 Doses Delivered As Of June 11\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-13 06:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 12 (Reuters) - </p><p>   * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 373,413,945 DOSES DELIVERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS ADMINISTERED 308,112,728 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 306,509,795 DOSES ADMINISTERED AS OF JUNE 11</p><p>   * U.S. CDC SAYS 173,391,711 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 172,758,350 INDIVIDUALS AS OF JUNE 11</p><p>   * U.S. CDC SAYS 143,119,077 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 12 VERSUS 142,095,530 INDIVIDUALS AS OF JUNE 11</p><p> Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","JNJ":"强生"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143783813","content_text":"June 12 (Reuters) -    * U.S. CDC SAYS DELIVERED 374,397,205 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 373,413,945 DOSES DELIVERED AS OF JUNE 11   * U.S. CDC SAYS ADMINISTERED 308,112,728 DOSES OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 306,509,795 DOSES ADMINISTERED AS OF JUNE 11   * U.S. CDC SAYS 173,391,711 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF JUNE 12 VERSUS 172,758,350 INDIVIDUALS AS OF JUNE 11   * U.S. CDC SAYS 143,119,077 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF JUNE 12 VERSUS 142,095,530 INDIVIDUALS AS OF JUNE 11 Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186124310,"gmtCreate":1623479724530,"gmtModify":1704204816543,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/186124310","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","IVV":"标普500指数ETF","DOG":"道指反向ETF","UPRO":"三倍做多标普500ETF","SSO":"两倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","OEF":"标普100指数ETF-iShares","QQQ":"纳指100ETF","SDS":"两倍做空标普500ETF","DXD":"道指两倍做空ETF","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","OEX":"标普100",".DJI":"道琼斯","TQQQ":"纳指三倍做多ETF","SH":"标普500反向ETF",".SPX":"S&P 500 Index","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166281354,"gmtCreate":1624011939778,"gmtModify":1703826512158,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"pls like and comment pls","listText":"pls like and comment pls","text":"pls like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166281354","repostId":"1166489816","repostType":4,"repost":{"id":"1166489816","kind":"news","pubTimestamp":1624009298,"share":"https://ttm.financial/m/news/1166489816?lang=&edition=fundamental","pubTime":"2021-06-18 17:41","market":"us","language":"en","title":"Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1166489816","media":"seekingalpha","summary":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine ","content":"<ul>\n <li>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase&nbsp;2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.</li>\n <li>The trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.</li>\n <li>Secondary endpoints include ORR in the single agent arms, duration of response, and safety.</li>\n <li>The first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.</li>\n <li>This Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.</li>\n <li>The Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).</li>\n <li>The BNT111-01 trial is being conducted in collaboration with Regeneron.</li>\n <li>BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-18 17:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed ...</p>\n\n<a href=\"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3707553-dosing-underway-in-biontechs-phase-2-trial-of-mrna-based-bnt111-in-advanced-melanoma","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1166489816","content_text":"BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed by Regeneron(NASDAQ:REGN)and Sanofi(NASDAQ:SNY)in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma.\nThe trial is enrolling a total of 120 patients. The primary endpoint is the overall response rate (ORR) of BNT111 in combination with Libtayo.\nSecondary endpoints include ORR in the single agent arms, duration of response, and safety.\nThe first patient has been dosed in the EU. BioNTech retains global commercial rights to BNT111.\nThis Phase 2 clinical trial is based on previous results from the Phase 1 Lipo-MERIT dose escalation trial that demonstrated a favorable safety profile in 89 patients with advanced melanoma.\nThe Company also plans to start randomized Phase 2 trials with mRNA vaccine product candidates in two additional programs in 2021 (FixVac: BNT113 and iNeST: BNT122).\nThe BNT111-01 trial is being conducted in collaboration with Regeneron.\nBioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant","news_type":1},"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104412423,"gmtCreate":1620402865162,"gmtModify":1704343290060,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"tough tough.. we all know there's a chip shortage and a shortage on touchscreens -&gt; this will probably hit GM production too. So just monitor for now.","listText":"tough tough.. we all know there's a chip shortage and a shortage on touchscreens -&gt; this will probably hit GM production too. So just monitor for now.","text":"tough tough.. we all know there's a chip shortage and a shortage on touchscreens -> this will probably hit GM production too. So just monitor for now.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/104412423","repostId":"2133688169","repostType":4,"repost":{"id":"2133688169","kind":"news","pubTimestamp":1620399721,"share":"https://ttm.financial/m/news/2133688169?lang=&edition=fundamental","pubTime":"2021-05-07 23:02","market":"us","language":"en","title":"Here's Why We Think General Motors Is Well Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2133688169","media":"Simply Wall St.","summary":"It's only natural that many investors, especially those who are new to the game, prefer to buy share","content":"<p>It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled <i>Who Falls Prey to the Wolf of Wall Street?'</i> Leuz et. al. found that it is 'quite common' for investors to lose money by buying into 'pump and dump' schemes.</p><p>In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like <b>General Motors</b> (NYSE:GM). While profit is not necessarily a social good, it's easy to admire a business that can consistently produce it. Loss-making companies are always racing against time to reach financial sustainability, but time is often a friend of the profitable company, especially if it is growing.</p><p>View our latest analysis for General Motors</p><h3>General Motors's Earnings Per Share Are Growing.</h3><p>The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. That means EPS growth is considered a real positive by most successful long-term investors. As a tree reaches steadily for the sky, General Motors's EPS has grown 31% each year, compound, over three years. If the company can sustain that sort of growth, we'd expect shareholders to come away winners.</p><p>Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. I note that General Motors's revenue <i>from operations</i> was lower than its revenue in the last twelve months, so that could distort my analysis of its margins. General Motors's EBIT margins have actually improved by 3.7 percentage points in the last year, to reach 8.9%, but, on the flip side, revenue was down 9.5%. That's not ideal.</p><p>You can take a look at the company's revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers.</p><p><img src=\"https://static.tigerbbs.com/2f3531ee5b167e8ef9aa142801c39a05\" tg-width=\"821\" tg-height=\"560\" referrerpolicy=\"no-referrer\">NYSE:GM Earnings and Revenue History May 7th 2021</p><p>You don't drive with your eyes on the rear-view mirror, so you might be more interested in this <b>free</b> report showing analyst forecasts for General Motors's <b>future</b> profits.</p><h3>Are General Motors Insiders Aligned With All Shareholders?</h3><p>Like standing at the lookout, surveying the horizon at sunrise, insider buying, for some investors, sparks joy. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. However, insiders are sometimes wrong, and we don't know the exact thinking behind their acquisitions.</p><p>It's good to see General Motors insiders walking the walk, by spending US$536k on shares in just twelve months. When you contrast that with the complete lack of sales, it's easy for shareholders to brim with joyful expectancy. It is also worth noting that it was Independent Director Patricia Russo who made the biggest single purchase, worth US$294k, paying US$23.18 per share.</p><p>On top of the insider buying, it's good to see that General Motors insiders have a valuable investment in the business. Notably, they have an enormous stake in the company, worth US$126m. This suggests to me that leadership will be very mindful of shareholders' interests when making decisions!</p><h3>Is General Motors Worth Keeping An Eye On?</h3><p>You can't deny that General Motors has grown its earnings per share at a very impressive rate. That's attractive. On top of that, insiders own a significant stake in the company and have been buying more shares. So it's fair to say I think this stock may well deserve a spot on your watchlist. We don't want to rain on the parade too much, but we did also find <b>1 warning sign for General Motors</b> that you need to be mindful of.</p><p>There are plenty of other companies that have insiders buying up shares. So if you like the sound of General Motors, you'll probably love this <b>free</b> list of growing companies that insiders are buying.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why We Think General Motors Is Well Worth Watching</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why We Think General Motors Is Well Worth Watching\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-07 23:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/heres-why-think-general-motors-092301076.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled...</p>\n\n<a href=\"https://finance.yahoo.com/news/heres-why-think-general-motors-092301076.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BGC":"BGC GROUP","GM":"通用汽车"},"source_url":"https://finance.yahoo.com/news/heres-why-think-general-motors-092301076.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2133688169","content_text":"It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks with a good story, even if those businesses lose money. And in their study titled Who Falls Prey to the Wolf of Wall Street?' Leuz et. al. found that it is 'quite common' for investors to lose money by buying into 'pump and dump' schemes.In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like General Motors (NYSE:GM). While profit is not necessarily a social good, it's easy to admire a business that can consistently produce it. Loss-making companies are always racing against time to reach financial sustainability, but time is often a friend of the profitable company, especially if it is growing.View our latest analysis for General MotorsGeneral Motors's Earnings Per Share Are Growing.The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. That means EPS growth is considered a real positive by most successful long-term investors. As a tree reaches steadily for the sky, General Motors's EPS has grown 31% each year, compound, over three years. If the company can sustain that sort of growth, we'd expect shareholders to come away winners.Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. I note that General Motors's revenue from operations was lower than its revenue in the last twelve months, so that could distort my analysis of its margins. General Motors's EBIT margins have actually improved by 3.7 percentage points in the last year, to reach 8.9%, but, on the flip side, revenue was down 9.5%. That's not ideal.You can take a look at the company's revenue and earnings growth trend, in the chart below. Click on the chart to see the exact numbers.NYSE:GM Earnings and Revenue History May 7th 2021You don't drive with your eyes on the rear-view mirror, so you might be more interested in this free report showing analyst forecasts for General Motors's future profits.Are General Motors Insiders Aligned With All Shareholders?Like standing at the lookout, surveying the horizon at sunrise, insider buying, for some investors, sparks joy. This view is based on the possibility that stock purchases signal bullishness on behalf of the buyer. However, insiders are sometimes wrong, and we don't know the exact thinking behind their acquisitions.It's good to see General Motors insiders walking the walk, by spending US$536k on shares in just twelve months. When you contrast that with the complete lack of sales, it's easy for shareholders to brim with joyful expectancy. It is also worth noting that it was Independent Director Patricia Russo who made the biggest single purchase, worth US$294k, paying US$23.18 per share.On top of the insider buying, it's good to see that General Motors insiders have a valuable investment in the business. Notably, they have an enormous stake in the company, worth US$126m. This suggests to me that leadership will be very mindful of shareholders' interests when making decisions!Is General Motors Worth Keeping An Eye On?You can't deny that General Motors has grown its earnings per share at a very impressive rate. That's attractive. On top of that, insiders own a significant stake in the company and have been buying more shares. So it's fair to say I think this stock may well deserve a spot on your watchlist. We don't want to rain on the parade too much, but we did also find 1 warning sign for General Motors that you need to be mindful of.There are plenty of other companies that have insiders buying up shares. So if you like the sound of General Motors, you'll probably love this free list of growing companies that insiders are buying.","news_type":1},"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160835505,"gmtCreate":1623778697807,"gmtModify":1703819283841,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"&nbsp;Like and reply pls","listText":"&nbsp;Like and reply pls","text":"Like and reply pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/160835505","repostId":"1147269544","repostType":4,"repost":{"id":"1147269544","kind":"news","pubTimestamp":1623770166,"share":"https://ttm.financial/m/news/1147269544?lang=&edition=fundamental","pubTime":"2021-06-15 23:16","market":"us","language":"en","title":"Michael \"Big Short\" Burry: This Is The Greatest Bubble Of All Time In All Things \"By Two Orders Of Magnitude\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1147269544","media":"zerohedge","summary":"Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he p","content":"<p>Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he picked up on the theme of Weimar Germany and specifically its<b>hyperinflation, as the blueprint for what comes next</b>in a lengthy tweetstorm cribbing generously fromParsson's seminal work, warning that<b>:</b></p>\n<p><b>\"The US government is inviting inflation with its MMT-tinged policies. Brisk Debt/GDP, M2 increases while retail sales, PMI stage V recovery</b>. Trillions more stimulus &amp; re-opening to boost demand as employee and supply chain costs skyrocket.\"</p>\n<p>#ParadigmShift</p>\n<p>\"The life of the inflation in its ripening stage was a paradox which had its own unmistakable characteristics. One was the great wealth, at least of those favored by the boom..Many great fortunes sprang up overnight...The cities, had an aimless and wanton youth\"</p>\n<p>\"Prices in Germany were steady, and both business and the stock market were booming. The exchange rate of the mark against the dollar and other currencies actually rose for a time, and the mark was momentarily the strongest currency in the world\" on inflation's eve.</p>\n<p><b>\"Side by side with the wealth were the pockets of poverty. Greater numbers of people remained on the outside of the easy money, looking in but not able to enter. The crime rate soared.\"</b></p>\n<p><b>\"Accounts of the time tell of a progressive demoralization which crept over the common people, compounded of their weariness with the breakneck pace, to no visible purpose, and their fears from watching their own precarious positions slip while others grew so conspicuously rich.\"</b></p>\n<p>\"Almost any kind of business could make money. Business failures and bankruptcies became few. The boom suspended the normal processes of natural selection by which the nonessential and ineffective otherwise would have been culled out.\"</p>\n<p><b>\"Speculation alone, while adding nothing to Germany's wealth, became one of its largest activities. The fever to join in turning a quick mark infected nearly all classes..Everyone from the elevator operator up was playing the market.\"</b></p>\n<p>\"The volumes of turnover in securities on the Berlin Bourse became so high that the financial industry could not keep up with the paperwork...and the Bourse was obliged to close several days a week to work off the backlog\" #<i>robinhooddown</i></p>\n<p>\"all the marks that existed in the world in the summer of 1922 were not worth enough, by November of 1923, to buy a single&nbsp; newspaper or a tram ticket. That was the spectacular part of the collapse, but most of the real loss in money wealth had been suffered much earlier.\"</p>\n<p>\"Throughout these years the structure was quietly building itself up for the blow.<b>Germany's #inflationcycle ran not for a year but for nine years, representing eight years of gestation and only one year of #collapse.\"</b></p>\n<p>His punchline: the above was \"written in 1974 re: 1914-1923\" and then makes the ominous extrapolation that \"<b>2010-2021: Gestation</b>\" adding that \"when dollars might as well be falling from the sky...management teams get creative and ultimately take more risk.. paying out debt-financed dividends to investors or investing in risky growth opportunities has beaten a frugal mentality hands down.\"</p>\n<p><img src=\"https://static.tigerbbs.com/c531b21050b42425510a30125935555e\" tg-width=\"500\" tg-height=\"395\">And, as if reading from the same playbook,<b>Paul Tudor Jones warned yesterday that things are \"bat shit crazy\"</b>and if Jay Powell</p>\n<blockquote>\n <i><b>“The idea that inflation is transitory, to me ... that one just doesn’t work the way I see the world.\"</b></i>\n</blockquote>\n<p>All of which led to Burry's latest tweet warning this morning...</p>\n<blockquote>\n <i><b>\"People always ask me what is going on in the markets. It is simple. Greatest Speculative Bubble of All Time in All Things. By two orders of magnitude.</b></i>#FlyingPigs360\"\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/afafeb68134e031ca871659bd8dbc595\" tg-width=\"512\" tg-height=\"261\">In other words:<i><b>\"Brace!\"</b></i></p>\n<p>So what are you going to do about it?</p>\n<p>Tudor Jones had some simple advice: \"<b>buy commodities, buy crypto, buy gold.\"</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Michael \"Big Short\" Burry: This Is The Greatest Bubble Of All Time In All Things \"By Two Orders Of Magnitude\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMichael \"Big Short\" Burry: This Is The Greatest Bubble Of All Time In All Things \"By Two Orders Of Magnitude\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/michael-big-short-burry-greatest-bubble-all-time-all-things-two-orders-magnitude><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he picked up on the theme of Weimar Germany and specifically itshyperinflation, as the blueprint for ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/michael-big-short-burry-greatest-bubble-all-time-all-things-two-orders-magnitude\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.zerohedge.com/markets/michael-big-short-burry-greatest-bubble-all-time-all-things-two-orders-magnitude","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147269544","content_text":"Earlier this year, none other than Michael 'Big Short' Burry confirmedBofA's greatest fears, as he picked up on the theme of Weimar Germany and specifically itshyperinflation, as the blueprint for what comes nextin a lengthy tweetstorm cribbing generously fromParsson's seminal work, warning that:\n\"The US government is inviting inflation with its MMT-tinged policies. Brisk Debt/GDP, M2 increases while retail sales, PMI stage V recovery. Trillions more stimulus & re-opening to boost demand as employee and supply chain costs skyrocket.\"\n#ParadigmShift\n\"The life of the inflation in its ripening stage was a paradox which had its own unmistakable characteristics. One was the great wealth, at least of those favored by the boom..Many great fortunes sprang up overnight...The cities, had an aimless and wanton youth\"\n\"Prices in Germany were steady, and both business and the stock market were booming. The exchange rate of the mark against the dollar and other currencies actually rose for a time, and the mark was momentarily the strongest currency in the world\" on inflation's eve.\n\"Side by side with the wealth were the pockets of poverty. Greater numbers of people remained on the outside of the easy money, looking in but not able to enter. The crime rate soared.\"\n\"Accounts of the time tell of a progressive demoralization which crept over the common people, compounded of their weariness with the breakneck pace, to no visible purpose, and their fears from watching their own precarious positions slip while others grew so conspicuously rich.\"\n\"Almost any kind of business could make money. Business failures and bankruptcies became few. The boom suspended the normal processes of natural selection by which the nonessential and ineffective otherwise would have been culled out.\"\n\"Speculation alone, while adding nothing to Germany's wealth, became one of its largest activities. The fever to join in turning a quick mark infected nearly all classes..Everyone from the elevator operator up was playing the market.\"\n\"The volumes of turnover in securities on the Berlin Bourse became so high that the financial industry could not keep up with the paperwork...and the Bourse was obliged to close several days a week to work off the backlog\" #robinhooddown\n\"all the marks that existed in the world in the summer of 1922 were not worth enough, by November of 1923, to buy a single  newspaper or a tram ticket. That was the spectacular part of the collapse, but most of the real loss in money wealth had been suffered much earlier.\"\n\"Throughout these years the structure was quietly building itself up for the blow.Germany's #inflationcycle ran not for a year but for nine years, representing eight years of gestation and only one year of #collapse.\"\nHis punchline: the above was \"written in 1974 re: 1914-1923\" and then makes the ominous extrapolation that \"2010-2021: Gestation\" adding that \"when dollars might as well be falling from the sky...management teams get creative and ultimately take more risk.. paying out debt-financed dividends to investors or investing in risky growth opportunities has beaten a frugal mentality hands down.\"\nAnd, as if reading from the same playbook,Paul Tudor Jones warned yesterday that things are \"bat shit crazy\"and if Jay Powell\n\n“The idea that inflation is transitory, to me ... that one just doesn’t work the way I see the world.\"\n\nAll of which led to Burry's latest tweet warning this morning...\n\n\"People always ask me what is going on in the markets. It is simple. Greatest Speculative Bubble of All Time in All Things. By two orders of magnitude.#FlyingPigs360\"\n\nIn other words:\"Brace!\"\nSo what are you going to do about it?\nTudor Jones had some simple advice: \"buy commodities, buy crypto, buy gold.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":583,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":186125636,"gmtCreate":1623479629825,"gmtModify":1704204815088,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"Trend trader&nbsp;","listText":"Trend trader&nbsp;","text":"Trend trader","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/186125636","repostId":"1147474880","repostType":2,"repost":{"id":"1147474880","kind":"news","pubTimestamp":1623470168,"share":"https://ttm.financial/m/news/1147474880?lang=&edition=fundamental","pubTime":"2021-06-12 11:56","market":"us","language":"en","title":"Investor, Trader, Speculator: Which One Are You?","url":"https://stock-news.laohu8.com/highlight/detail?id=1147474880","media":"The Wall Street Journal","summary":"Understanding the difference between speculation and investing is essential to avoiding reckless ris","content":"<blockquote>\n Understanding the difference between speculation and investing is essential to avoiding reckless risk.\n</blockquote>\n<p>I’ve had it.</p>\n<p>The Wall Street Journal is wrong, and has remained wrong for decades, about one of the most basic distinctions in finance. And I can’t stand it anymore.</p>\n<p>If you buy a stock purely because it’s gone up a lot, without doing any research on it whatsoever, you are not—as the Journal and its editors bizarrely insist on calling you—an “investor.” If you buy a cryptocurrency because, hey, that sounds like fun, you aren’t an investor either.</p>\n<p>Whenever you buy any financial asset becauseyou have a hunchorjust for kicks, or becausesomebody famous is hyping the heck out of itoreverybody else seems to be buying it too, you aren’t investing.</p>\n<p>You’re definitely a trader: someone who has just bought an asset. And you may bea speculator: someone who thinks other people will pay more for it than you did.</p>\n<p>Of course,some folkswho buy meme stocks likeGameStopCorp.GME5.88%<i>are</i>investors. They read the companies’ financial statements, study the health of the underlying businesses and learn who else is betting on or against the shares. Likewise, many buyers of digital coins have put in the time and effort to understand how cryptocurrency works and how it could reshape finance.</p>\n<p>An investor relies on internal sources of return: earnings, income, growth in the value of assets. A speculator counts on external sources of return: primarilywhether somebody else will pay more, regardless of fundamental value.</p>\n<p>The word investor comes from the Latin “investire,” to dress in or clothe oneself, surround or envelop. You would never wear clothes without knowing what color they are or what material they’re made of. Likewise, you can’t invest in an asset you know nothing about.</p>\n<p>Nevertheless, the Journal and its editors have long called almost everybody who buys just about anything an “investor.” On July 12, 1962, the Journal publisheda letter to the editorfrom Benjamin Graham, author of the classic books “Security Analysis” and “The Intelligent Investor.” That June, complained Graham, the Journal had run an article headlined “Many Small Investors Bet on Further Drops, Sell Odd Lots Short.”</p>\n<p>He wrote: “By what definition of ‘investment’ can one give the name ‘investors’ to small people who make bets on the stock market by selling odd lots short?” (To short an odd lot is to borrow and sell fewer than 100 shares in a wager that a stock will fall—an expensive and risky bet, then and now.)</p>\n<p>“If these people are investors,” asked Graham, “how should one define ‘speculation’ and ‘speculators’? Isn’t it possible that the currentfailure to distinguishbetweeninvestment and speculationmay do grave harm not only to individuals but to the whole financial community—as it did in the late 1920s?”</p>\n<p>Graham wasn’t a snob who thought that the markets should be the exclusive playground of the rich. He wrote “The Intelligent Investor” with the express purpose of helping less-wealthy people participate wisely in the stock market.</p>\n<p>In that book, after which this column is named, Graham said, “Outright speculation is neither illegal, immoral, nor (for most people) fattening to the pocketbook.”</p>\n<p>However, he warned, it creates three dangers: “(1) speculating when you think you are investing; (2) speculating seriously instead of as a pastime, when you lack proper knowledge and skill for it; and (3) risking more money in speculation than you can afford to lose.”</p>\n<p>Most investors speculate a bit every once in a while. Like a lottery ticket or an occasional visit to the racetrack or casino, a little is harmless fun. A lot isn’t.</p>\n<p>If you think you’re investing when you’re speculating, you’ll attribute even momentary success to skill even thoughluck is the likeliest explanation. That can lead you to take reckless risks.</p>\n<p>Take speculating too seriously, and it turns intoan obsessionandan addiction. You become incapable of accepting your losses or focusing on the future more than a few minutes ahead. Next thing you know, you’re throwing even more money onto the bonfire.</p>\n<p>I think calling traders and speculators “investors” shoves many newcomers farther down the slippery slope toward risks they shouldn’t take and losses they can’t afford. I fervently hope the Journal and its editors will finally stop using “investor” as the default term for anyone who makes a trade.</p>\n<p>“ ‘Investor’ has a long history in the English language as a catch-all term denoting people who commit capital with the expectation of a return, no matter how long or short, no matter how many or how few investing columns they read,” WSJ Financial Editor Charles Forelle said in response to my complaints. “Back at least to the mid-19th century, ‘invest’ has even been used to describe a wager on horses—an activity surely no less divorced from fundamental analysis than a purchase of dogecoin.”</p>\n<p>I hear you, Boss, but I still think you’re wrong. There’s no way the Journal would say a recreational gambler is “investing” at the racetrack just because a dictionary says we can.</p>\n<p>Calling novice speculators “investors” is one of the most powerful ways marketers fuel excessive trading.</p>\n<p>Ina recent Instagram post, a former porn star who goes by the name Lana Rhoades posed in—well, mostly in—a bikini, as she held up what appears to be Graham’s “The Intelligent Investor.” According to IMDb.com, she starred in such videos as “Tushy” and “Make Me Meow.”</p>\n<p>In her post, which was “liked” by nearly 1.8 million people, Ms. Rhoades announced that she will be promoting a cryptocurrency calledPAWGcoin.</p>\n<p>The currency’s website says the coin is meant for “those who pay homage to developed posteriors.” (PAWG, I’ve been reliably informed, stands for Phat Ass White Girl.)</p>\n<p>PAWGcoin is up roughly 900% since Ms. Rhoades began promoting it in early June, according to Poocoin.io, a website that tracks such digital currencies.</p>\n<p>Ms. Rhoades, who has tweeted “I also read the WSJ every morning,” couldn’t be reached for comment. PAWGcoin’s website encourages visitors to “invest now.”</p>\n<p>In Ms. Rhoades’s Instagram post, she is holding up an open copy of the “The Intelligent Investor,” whose cover is reversed. She appears to be reading it with her eyes closed.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investor, Trader, Speculator: Which One Are You?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestor, Trader, Speculator: Which One Are You?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 11:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/you-cant-invest-without-trading-you-can-trade-without-investing-11623426213?mod=markets_lead_pos5><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Understanding the difference between speculation and investing is essential to avoiding reckless risk.\n\nI’ve had it.\nThe Wall Street Journal is wrong, and has remained wrong for decades, about one of ...</p>\n\n<a href=\"https://www.wsj.com/articles/you-cant-invest-without-trading-you-can-trade-without-investing-11623426213?mod=markets_lead_pos5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.wsj.com/articles/you-cant-invest-without-trading-you-can-trade-without-investing-11623426213?mod=markets_lead_pos5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147474880","content_text":"Understanding the difference between speculation and investing is essential to avoiding reckless risk.\n\nI’ve had it.\nThe Wall Street Journal is wrong, and has remained wrong for decades, about one of the most basic distinctions in finance. And I can’t stand it anymore.\nIf you buy a stock purely because it’s gone up a lot, without doing any research on it whatsoever, you are not—as the Journal and its editors bizarrely insist on calling you—an “investor.” If you buy a cryptocurrency because, hey, that sounds like fun, you aren’t an investor either.\nWhenever you buy any financial asset becauseyou have a hunchorjust for kicks, or becausesomebody famous is hyping the heck out of itoreverybody else seems to be buying it too, you aren’t investing.\nYou’re definitely a trader: someone who has just bought an asset. And you may bea speculator: someone who thinks other people will pay more for it than you did.\nOf course,some folkswho buy meme stocks likeGameStopCorp.GME5.88%areinvestors. They read the companies’ financial statements, study the health of the underlying businesses and learn who else is betting on or against the shares. Likewise, many buyers of digital coins have put in the time and effort to understand how cryptocurrency works and how it could reshape finance.\nAn investor relies on internal sources of return: earnings, income, growth in the value of assets. A speculator counts on external sources of return: primarilywhether somebody else will pay more, regardless of fundamental value.\nThe word investor comes from the Latin “investire,” to dress in or clothe oneself, surround or envelop. You would never wear clothes without knowing what color they are or what material they’re made of. Likewise, you can’t invest in an asset you know nothing about.\nNevertheless, the Journal and its editors have long called almost everybody who buys just about anything an “investor.” On July 12, 1962, the Journal publisheda letter to the editorfrom Benjamin Graham, author of the classic books “Security Analysis” and “The Intelligent Investor.” That June, complained Graham, the Journal had run an article headlined “Many Small Investors Bet on Further Drops, Sell Odd Lots Short.”\nHe wrote: “By what definition of ‘investment’ can one give the name ‘investors’ to small people who make bets on the stock market by selling odd lots short?” (To short an odd lot is to borrow and sell fewer than 100 shares in a wager that a stock will fall—an expensive and risky bet, then and now.)\n“If these people are investors,” asked Graham, “how should one define ‘speculation’ and ‘speculators’? Isn’t it possible that the currentfailure to distinguishbetweeninvestment and speculationmay do grave harm not only to individuals but to the whole financial community—as it did in the late 1920s?”\nGraham wasn’t a snob who thought that the markets should be the exclusive playground of the rich. He wrote “The Intelligent Investor” with the express purpose of helping less-wealthy people participate wisely in the stock market.\nIn that book, after which this column is named, Graham said, “Outright speculation is neither illegal, immoral, nor (for most people) fattening to the pocketbook.”\nHowever, he warned, it creates three dangers: “(1) speculating when you think you are investing; (2) speculating seriously instead of as a pastime, when you lack proper knowledge and skill for it; and (3) risking more money in speculation than you can afford to lose.”\nMost investors speculate a bit every once in a while. Like a lottery ticket or an occasional visit to the racetrack or casino, a little is harmless fun. A lot isn’t.\nIf you think you’re investing when you’re speculating, you’ll attribute even momentary success to skill even thoughluck is the likeliest explanation. That can lead you to take reckless risks.\nTake speculating too seriously, and it turns intoan obsessionandan addiction. You become incapable of accepting your losses or focusing on the future more than a few minutes ahead. Next thing you know, you’re throwing even more money onto the bonfire.\nI think calling traders and speculators “investors” shoves many newcomers farther down the slippery slope toward risks they shouldn’t take and losses they can’t afford. I fervently hope the Journal and its editors will finally stop using “investor” as the default term for anyone who makes a trade.\n“ ‘Investor’ has a long history in the English language as a catch-all term denoting people who commit capital with the expectation of a return, no matter how long or short, no matter how many or how few investing columns they read,” WSJ Financial Editor Charles Forelle said in response to my complaints. “Back at least to the mid-19th century, ‘invest’ has even been used to describe a wager on horses—an activity surely no less divorced from fundamental analysis than a purchase of dogecoin.”\nI hear you, Boss, but I still think you’re wrong. There’s no way the Journal would say a recreational gambler is “investing” at the racetrack just because a dictionary says we can.\nCalling novice speculators “investors” is one of the most powerful ways marketers fuel excessive trading.\nIna recent Instagram post, a former porn star who goes by the name Lana Rhoades posed in—well, mostly in—a bikini, as she held up what appears to be Graham’s “The Intelligent Investor.” According to IMDb.com, she starred in such videos as “Tushy” and “Make Me Meow.”\nIn her post, which was “liked” by nearly 1.8 million people, Ms. Rhoades announced that she will be promoting a cryptocurrency calledPAWGcoin.\nThe currency’s website says the coin is meant for “those who pay homage to developed posteriors.” (PAWG, I’ve been reliably informed, stands for Phat Ass White Girl.)\nPAWGcoin is up roughly 900% since Ms. Rhoades began promoting it in early June, according to Poocoin.io, a website that tracks such digital currencies.\nMs. Rhoades, who has tweeted “I also read the WSJ every morning,” couldn’t be reached for comment. PAWGcoin’s website encourages visitors to “invest now.”\nIn Ms. Rhoades’s Instagram post, she is holding up an open copy of the “The Intelligent Investor,” whose cover is reversed. She appears to be reading it with her eyes closed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189666684,"gmtCreate":1623256868248,"gmtModify":1704199606263,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ON\">$ON Semiconductor(ON)$</a> anyone crazy enough to be bearish on ON?","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/ON\">$ON Semiconductor(ON)$</a> anyone crazy enough to be bearish on ON?","text":"$ON Semiconductor(ON)$ anyone crazy enough to be bearish on ON?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189666684","isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104414615,"gmtCreate":1620403000637,"gmtModify":1704343292683,"author":{"id":"3582093977648076","authorId":"3582093977648076","name":"Enzorurong","avatar":"https://static.tigerbbs.com/efd88cd4507cdd831cb9bed9cf04c209","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582093977648076","authorIdStr":"3582093977648076"},"themes":[],"htmlText":"monitor NXP, Infineon Technologies AG and Renesas Electronics Corp","listText":"monitor NXP, Infineon Technologies AG and Renesas Electronics Corp","text":"monitor NXP, Infineon Technologies AG and Renesas Electronics Corp","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/104414615","repostId":"1139108781","repostType":4,"repost":{"id":"1139108781","kind":"news","pubTimestamp":1620397966,"share":"https://ttm.financial/m/news/1139108781?lang=&edition=fundamental","pubTime":"2021-05-07 22:32","market":"us","language":"en","title":"U.S. lawmakers should prioritize automotive chips needs: industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1139108781","media":"Reuters","summary":"WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress","content":"<p>WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress to tie billions of dollars in government funding to boost semiconductor production to chip needs of automakers forced to slash production because of shortages.</p><p>Congress “should prioritize production of the semiconductors necessary to assemble vehicles here in the United States. This will ensure that motor vehicle manufacturers have a fair share of chips needed to meet consumer demand,” said the American Automotive Policy Council, Motor &amp; Equipment Manufacturers Association and UAW on Friday in a joint statement. Tens of thousands of auto workers have faced layoffs because of production cuts due to chip shortages.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. lawmakers should prioritize automotive chips needs: industry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. lawmakers should prioritize automotive chips needs: industry\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-07 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/autos-semiconductors-congress/u-s-lawmakers-should-prioritize-automotive-chips-needs-industry-idUSL1N2MU16V><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress to tie billions of dollars in government funding to boost semiconductor production to chip needs of...</p>\n\n<a href=\"https://www.reuters.com/article/autos-semiconductors-congress/u-s-lawmakers-should-prioritize-automotive-chips-needs-industry-idUSL1N2MU16V\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.reuters.com/article/autos-semiconductors-congress/u-s-lawmakers-should-prioritize-automotive-chips-needs-industry-idUSL1N2MU16V","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139108781","content_text":"WASHINGTON (Reuters) - The U.S. auto industry and United Auto Workers union on Friday urged Congress to tie billions of dollars in government funding to boost semiconductor production to chip needs of automakers forced to slash production because of shortages.Congress “should prioritize production of the semiconductors necessary to assemble vehicles here in the United States. This will ensure that motor vehicle manufacturers have a fair share of chips needed to meet consumer demand,” said the American Automotive Policy Council, Motor & Equipment Manufacturers Association and UAW on Friday in a joint statement. Tens of thousands of auto workers have faced layoffs because of production cuts due to chip shortages.","news_type":1},"isVote":1,"tweetType":1,"viewCount":489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}